CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $158,000 | +129.0% | 132,775 | +245.7% | 0.00% | – |
Q2 2022 | $69,000 | -55.2% | 38,408 | -49.6% | 0.00% | – |
Q1 2022 | $154,000 | -81.1% | 76,274 | -74.6% | 0.00% | – |
Q4 2021 | $814,000 | +214.3% | 299,892 | +416.7% | 0.00% | – |
Q3 2021 | $259,000 | +43.1% | 58,039 | +85.1% | 0.00% | – |
Q2 2021 | $181,000 | -71.0% | 31,358 | -64.7% | 0.00% | – |
Q1 2021 | $624,000 | -55.3% | 88,935 | -69.4% | 0.00% | – |
Q4 2020 | $1,395,000 | -40.3% | 290,741 | -27.5% | 0.00% | -100.0% |
Q3 2020 | $2,336,000 | -47.2% | 400,902 | -38.8% | 0.00% | -66.7% |
Q2 2020 | $4,421,000 | +16.7% | 655,206 | +10.0% | 0.00% | 0.0% |
Q1 2020 | $3,788,000 | -62.4% | 595,512 | -38.4% | 0.00% | -50.0% |
Q4 2019 | $10,082,000 | +563.3% | 967,048 | +150.1% | 0.01% | +500.0% |
Q3 2019 | $1,520,000 | -60.7% | 386,733 | +48.5% | 0.00% | -50.0% |
Q2 2019 | $3,872,000 | -0.2% | 260,436 | +66.6% | 0.00% | -33.3% |
Q1 2019 | $3,879,000 | +20.7% | 156,324 | -12.6% | 0.00% | 0.0% |
Q4 2018 | $3,214,000 | -52.3% | 178,918 | -22.0% | 0.00% | -40.0% |
Q3 2018 | $6,733,000 | -46.8% | 229,276 | -17.6% | 0.01% | -54.5% |
Q2 2018 | $12,645,000 | +9.7% | 278,116 | +27.3% | 0.01% | +22.2% |
Q1 2018 | $11,530,000 | -75.5% | 218,390 | -68.4% | 0.01% | -76.9% |
Q4 2017 | $47,043,000 | +105.3% | 691,824 | +148.8% | 0.04% | +62.5% |
Q3 2017 | $22,915,000 | -57.6% | 278,102 | -51.8% | 0.02% | -59.3% |
Q2 2017 | $54,066,000 | +1201.5% | 577,442 | +785.4% | 0.06% | +1080.0% |
Q1 2017 | $4,154,000 | -71.6% | 65,221 | -80.2% | 0.01% | -68.8% |
Q4 2016 | $14,613,000 | +281.0% | 328,967 | +209.3% | 0.02% | +220.0% |
Q3 2016 | $3,835,000 | +149.0% | 106,373 | -5.2% | 0.01% | +150.0% |
Q2 2016 | $1,540,000 | -55.6% | 112,178 | -38.6% | 0.00% | -60.0% |
Q1 2016 | $3,469,000 | +80.3% | 182,586 | +232.3% | 0.01% | +150.0% |
Q4 2015 | $1,924,000 | -9.6% | 54,949 | +134.9% | 0.00% | -33.3% |
Q3 2015 | $2,128,000 | -62.4% | 23,388 | -64.0% | 0.00% | -50.0% |
Q2 2015 | $5,657,000 | +3883.8% | 65,014 | +3287.9% | 0.01% | – |
Q1 2015 | $142,000 | +51.1% | 1,919 | +15.0% | 0.00% | – |
Q4 2014 | $94,000 | -66.4% | 1,668 | -73.1% | 0.00% | – |
Q3 2014 | $280,000 | -97.4% | 6,194 | -97.7% | 0.00% | -100.0% |
Q2 2014 | $10,921,000 | +2343.2% | 266,370 | +3996.7% | 0.01% | +1100.0% |
Q1 2014 | $447,000 | -30.7% | 6,502 | -39.6% | 0.00% | 0.0% |
Q4 2013 | $645,000 | -25.9% | 10,757 | -25.9% | 0.00% | 0.0% |
Q3 2013 | $871,000 | +580.5% | 14,519 | +658.6% | 0.00% | – |
Q2 2013 | $128,000 | – | 1,914 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |